New drug aims to shield patients from harsh chemoradiation side effects

This study is testing a new drug called BMX-001, given alongside the standard treatment of radiation and chemotherapy for newly diagnosed anal cancer. The main goal is to see if BMX-001 can protect healthy tissues from damage, reducing severe side effects like skin burns, rectal pain, and bladder problems, while also helping to kill the tumor. Researchers will first find the safest dose and then see how well it works in a small group of 24 patients.